###
中国临床研究:2024,37(9):1323-1326
本文二维码信息
码上扫一扫!
T细胞在结直肠癌中的作用及相关治疗进展
(1. 济宁医学院临床医学院,山东 济宁 272067;2. 济宁医学院附属医院临床药学科,山东 济宁 272029;3. 济宁医学院附属医院病理科,山东 济宁 272029)
Advances in the role of T cells in colorectal cancer and related therapies
(1.Clinical School of Medicine, Jining Medical University, Jining, Shandong 272067, China;2.Clinical Pharmacy Department, Affiliated Hospital of Jining Medical University , Jining, Shandong 272029, China;3.Pathology Department, Affiliated Hospital of Jining Medical University , Jining, Shandong 272029, China)
摘要
本文已被:浏览 47次   下载 65
投稿时间:2024-03-05   网络发布日期:2024-09-21
中文摘要: T细胞与肿瘤的发生发展及肿瘤微环境(TME)稳态密切相关。其表面免疫检查点共受体共同调节着免疫应答。它可通过分泌各种物质抑制或杀伤肿瘤细胞,纠正和恢复受损的抗肿瘤免疫反应。近年来,靶向T细胞治疗获得一些进展,但一些新的免疫检查靶点仍在研究中。本文重点探讨T细胞在调控结直肠癌(CRC)和TME中的作用、CRC的免疫耐药机制及其靶向治疗等,论述T细胞对CRC发生发展的相关影响及靶向T细胞治疗CRC的应用前景。
Abstract:T cells are closely associated with tumor development and the homeostasis of the tumor microenvironment (TME). The co-receptors of immune checkpoints on the surface of T cells collectively regulate immune responses and can inhibit or kill tumor cells by secreting various substances, correcting and restoring impaired anti-tumor immune responses. In recent years, there has been some progress in targeted T cell therapy, but some new immune test targets are still being studied. This article focuses on the role of T cells in the regulation of colorectal cancer (CRC) and TME, the mechanism of immune resistance to CRC and its targeted therapy, and discusses the relevant effects of T cells on the occurrence and development of CRC and the application prospect of targeted T cell therapy for CRC.
文章编号:     中图分类号:R735.3    文献标志码:A
基金项目:济宁市重点研发计划项目(2023YXNS062);济宁医学院高层次科研项目培育计划项目(JYGC2022FKJ014)
引用文本:
李月天,黄海宁,陈帅,等.T细胞在结直肠癌中的作用及相关治疗进展[J].中国临床研究,2024,37(9):1323-1326.

用微信扫一扫

用微信扫一扫